Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Brian P Mckeon. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Brian P Mckeon har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:XRAY / DENTSPLY SIRONA Inc. | Director | 28 887 |
| US:ALKS / Alkermes plc | Director | 38 536 |
| US:IDXX / IDEXX Laboratories, Inc. | EVP, CFO and Treasurer | 31 550 |
| US:04685W103 / athenahealth, Inc. | Director | 0 |
| US:IRM / Iron Mountain Incorporated | Chief Financial Officer | 10 991 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Brian P Mckeon. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ALKS / Alkermes plc - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ALKS / Alkermes plc. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-02 | ALKS | MCKEON BRIAN P | 10 000 | 26,4269 | 10 000 | 26,4269 | 264 269 | 57 | 32.13 | 57 031 | 21,58 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ALKS / Alkermes plc. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Brian P Mckeon som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 |
|
4 | XRAY |
DENTSPLY SIRONA Inc.
Common Stock |
A - Award | 28 887 | 28 887 | |||||
| 2026-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 475 | 38 536 | −3,69 | 36,95 | −54 501 | 1 423 905 | |
| 2026-05-22 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 6 142 | 40 011 | 18,13 | ||||
| 2025-06-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 924 | 33 869 | −5,38 | 30,61 | −58 894 | 1 036 730 | |
| 2025-06-02 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 8 013 | 35 793 | 28,84 | ||||
| 2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −569 | 31 550 | −1,77 | 444,53 | −252 938 | 14 024 740 | |
| 2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 299 | 32 119 | 0,94 | ||||
| 2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 308 | 31 820 | 0,98 | ||||
| 2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 303 | 31 512 | 0,97 | ||||
| 2025-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 252 | 31 209 | 0,81 | ||||
| 2024-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −117 | 30 932 | −0,38 | 455,08 | −53 244 | 14 076 349 | |
| 2024-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 31 049 | 0,62 | ||||
| 2024-07-01 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 465 | 27 780 | −5,01 | 24,10 | −35 306 | 669 498 | |
| 2024-07-01 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 6 104 | 29 245 | 26,38 | ||||
| 2024-02-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 483 | 30 835 | 1,59 | 206,94 | 99 952 | 6 380 911 | |
| 2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 097 | 30 352 | −3,49 | 560,56 | −614 934 | 17 013 889 | |
| 2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 308 | 31 449 | 0,99 | ||||
| 2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 303 | 31 141 | 0,98 | ||||
| 2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 253 | 30 838 | 0,83 | ||||
| 2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 432 | 30 585 | 1,43 | ||||
| 2024-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 30 153 | 1,46 | ||||
| 2024-02-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 088 | 23 141 | −4,49 | 27,32 | −29 724 | 632 212 | |
| 2024-02-13 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 4 533 | 24 229 | 23,01 | ||||
| 2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −681 | 29 718 | −2,24 | 572,80 | −390 080 | 17 022 359 | |
| 2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −7 128 | 30 399 | −18,99 | 571,84 | −4 076 062 | 17 383 073 | |
| 2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −5 675 | 37 527 | −13,14 | 570,97 | −3 240 253 | 21 426 547 | |
| 2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 912 | 43 202 | −8,30 | 569,91 | −2 229 500 | 24 621 158 | |
| 2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 469 | 47 114 | −3,02 | 568,84 | −835 633 | 26 800 327 | |
| 2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 564 | 48 583 | −3,12 | 567,35 | −887 333 | 27 563 271 | |
| 2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −701 | 50 147 | −1,38 | 566,53 | −397 140 | 28 409 700 | |
| 2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 581 | 50 848 | −3,02 | 564,98 | −893 227 | 28 727 669 | |
| 2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −615 | 52 429 | −1,16 | 563,82 | −346 747 | 29 560 069 | |
| 2024-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 23 326 | 53 044 | 78,49 | 141,60 | 3 302 962 | 7 510 973 | |
| 2023-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −117 | 29 692 | −0,39 | 504,08 | −58 977 | 14 967 318 | |
| 2023-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 29 809 | 0,65 | ||||
| 2023-07-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 430 | 19 696 | −6,77 | 29,88 | −42 728 | 588 516 | |
| 2023-07-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 5 957 | 21 126 | 39,27 | ||||
| 2023-05-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 560 | 29 605 | 1,93 | 178,26 | 99 826 | 5 277 449 | |
| 2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 208 | 29 031 | −3,99 | 503,65 | −608 409 | 14 621 283 | |
| 2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 303 | 30 239 | 1,01 | ||||
| 2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 253 | 29 936 | 0,85 | ||||
| 2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 433 | 29 683 | 1,48 | ||||
| 2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 29 250 | 1,51 | ||||
| 2023-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 504 | 28 815 | 1,78 | ||||
| 2023-02-10 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 4 445 | 15 169 | 41,45 | ||||
| 2022-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −90 | 28 276 | −0,32 | 407,78 | −36 700 | 11 530 242 | |
| 2022-08-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 28 366 | 0,68 | ||||
| 2022-06-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −795 | 10 724 | −6,90 | 27,19 | −21 616 | 291 586 | |
| 2022-06-16 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 7 585 | 11 519 | 192,81 | ||||
| 2022-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −706 | 0 | −100,00 | ||||
| 2022-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 706 | 28 154 | 2,57 | 141,60 | 99 970 | 3 986 556 | |
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −253 | 4 785 | −5,02 | ||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −433 | 5 038 | −7,91 | ||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −435 | 5 471 | −7,37 | ||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −505 | 5 906 | −7,88 | ||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −459 | 6 411 | −6,68 | ||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 212 | 6 870 | 21,42 | ||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 197 | 197 | |||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 10 502 | 10 502 | |||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −964 | 27 448 | −3,39 | 505,53 | −487 331 | 13 875 607 | |
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 253 | 28 412 | 0,90 | ||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 433 | 28 159 | 1,56 | ||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 27 726 | 1,59 | ||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 27 291 | 1,89 | ||||
| 2022-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 26 786 | 1,74 | ||||
| 2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −4 446 | 8 890 | −33,34 | ||||
| 2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
M - Exercise | −2 223 | 0 | −100,00 | ||||
| 2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −1 823 | 3 934 | −31,67 | 23,55 | −42 932 | 92 646 | |
| 2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 4 446 | 5 757 | 339,13 | ||||
| 2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
F - Taxes | −912 | 1 311 | −41,03 | 23,55 | −21 478 | 30 874 | |
| 2022-02-11 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
M - Exercise | 2 223 | 2 223 | |||||
| 2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −9 225 | 0 | −100,00 | ||||
| 2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 273 | 26 317 | −7,95 | 621,26 | −1 412 126 | 16 349 501 | |
| 2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −6 952 | 28 590 | −19,56 | 620,55 | −4 314 062 | 17 741 297 | |
| 2021-11-15 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 9 225 | 35 542 | 35,05 | 67,85 | 625 916 | 2 411 500 | |
| 2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −20 000 | 9 225 | −68,43 | ||||
| 2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −872 | 26 317 | −3,21 | 629,80 | −549 186 | 16 574 232 | |
| 2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 375 | 27 189 | −4,81 | 628,78 | −864 574 | 17 095 707 | |
| 2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 974 | 28 564 | −9,43 | 627,97 | −1 867 572 | 17 937 008 | |
| 2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 813 | 31 538 | −5,44 | 626,74 | −1 136 282 | 19 765 937 | |
| 2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 326 | 33 351 | −6,52 | 625,46 | −1 454 831 | 20 859 650 | |
| 2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 142 | 35 677 | −5,66 | 624,53 | −1 337 747 | 22 281 198 | |
| 2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 493 | 37 819 | −3,80 | 623,34 | −930 649 | 23 573 933 | |
| 2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −5 743 | 39 312 | −12,75 | 622,36 | −3 574 235 | 24 466 139 | |
| 2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 262 | 45 055 | −2,72 | 621,40 | −784 203 | 27 996 820 | |
| 2021-11-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 20 000 | 46 317 | 76,00 | 67,85 | 1 357 000 | 3 142 584 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −6 310 | 29 225 | −17,76 | ||||
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −607 | 26 317 | −2,25 | 631,01 | −383 024 | 16 606 086 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −5 703 | 26 924 | −17,48 | 630,13 | −3 593 652 | 16 965 495 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 6 310 | 32 627 | 23,98 | 67,85 | 428 134 | 2 213 718 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −10 000 | 35 535 | −21,96 | ||||
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −110 | 26 317 | −0,42 | 632,19 | −69 541 | 16 637 176 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −743 | 26 427 | −2,73 | 631,39 | −469 122 | 16 685 478 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −971 | 27 170 | −3,45 | 630,39 | −612 112 | 17 127 572 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 094 | 28 141 | −6,93 | 629,63 | −1 318 446 | 17 718 207 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 356 | 30 235 | −7,23 | 628,19 | −1 480 024 | 18 993 206 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 326 | 32 591 | −3,91 | 627,41 | −831 942 | 20 447 594 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 100 | 33 917 | −3,14 | 626,47 | −689 122 | 21 247 918 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 300 | 35 017 | −3,58 | 625,25 | −812 824 | 21 894 131 | |
| 2021-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 10 000 | 36 317 | 38,00 | 67,85 | 678 500 | 2 464 084 | |
| 2021-08-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −192 | 5 658 | −3,28 | ||||
| 2021-08-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −96 | 26 308 | −0,36 | 705,76 | −67 753 | 18 566 882 | |
| 2021-08-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 192 | 26 404 | 0,73 | ||||
| 2021-08-04 |
|
4 | ALKS |
Alkermes plc.
Ordinary Shares |
P - Purchase | 10 000 | 10 000 | 26,43 | 264 269 | 264 269 | ||
| 2021-06-16 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 7 585 | 7 585 | |||||
| 2021-06-16 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
A - Award | 15 677 | 15 677 | |||||
| 2021-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 474 | 0 | −100,00 | ||||
| 2021-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 474 | 26 188 | 5,96 | 67,85 | 100 011 | 1 776 856 | |
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 307 | 24 714 | −5,02 | 539,58 | −705 231 | 13 335 180 | |
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −433 | 5 850 | −6,89 | ||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −435 | 6 283 | −6,48 | ||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −505 | 6 718 | −6,99 | ||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −459 | 7 223 | −5,98 | ||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −810 | 7 682 | −9,54 | ||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 011 | 8 492 | 13,51 | ||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 183 | 183 | |||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 9 538 | 9 538 | |||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 335 | 26 021 | −4,88 | 544,08 | −726 347 | 14 157 506 | |
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 433 | 27 356 | 1,61 | ||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 26 923 | 1,64 | ||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 26 488 | 1,94 | ||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 25 983 | 1,80 | ||||
| 2021-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 810 | 25 524 | 3,28 | ||||
| 2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 2 223 | 2 223 | |||||
| 2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
A - Award | 4 549 | 4 549 | |||||
| 2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Restricted Stock Unit Award |
A - Award | 13 336 | 13 336 | |||||
| 2021-02-11 |
|
4 | ALKS |
Alkermes plc.
Non Qualified Stock Option (Right to Buy) |
A - Award | 26 169 | 26 169 | |||||
| 2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 000 | 18 050 | −14,25 | 478,13 | −1 434 380 | 8 630 189 | |
| 2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 100 | 21 050 | −9,07 | 476,89 | −1 001 466 | 10 038 503 | |
| 2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −300 | 23 150 | −1,28 | 475,50 | −142 650 | 11 007 825 | |
| 2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 338 | 23 450 | −12,46 | 475,02 | −1 585 625 | 11 139 278 | |
| 2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 241 | 26 788 | −4,43 | 474,14 | −588 404 | 12 701 177 | |
| 2020-11-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −21 | 28 029 | −0,07 | 472,88 | −9 931 | 13 254 418 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −36 216 | 0 | −100,00 | ||||
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −200 | 24 700 | −0,80 | 481,26 | −96 252 | 11 887 122 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −566 | 24 900 | −2,22 | 480,31 | −271 854 | 11 959 639 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 534 | 25 466 | −5,68 | 479,69 | −735 851 | 12 215 900 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −390 | 27 000 | −1,42 | 477,02 | −186 036 | 12 879 446 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 596 | 27 390 | −11,61 | 476,01 | −1 711 740 | 13 037 974 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 474 | 30 986 | −10,08 | 475,20 | −1 650 846 | 14 724 560 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −244 | 34 460 | −0,70 | 473,97 | −115 648 | 16 332 934 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 407 | 34 704 | −6,49 | 473,04 | −1 138 602 | 16 416 300 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 107 | 37 111 | −2,90 | 472,20 | −522 721 | 17 523 666 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 493 | 38 218 | −6,12 | 471,02 | −1 174 259 | 18 001 534 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 850 | 40 711 | −6,54 | 469,80 | −1 338 921 | 19 125 898 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −9 617 | 43 561 | −18,08 | 469,09 | −4 511 281 | 20 434 221 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −6 338 | 53 178 | −10,65 | 467,97 | −2 965 970 | 24 885 507 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 400 | 59 516 | −2,30 | 467,01 | −653 820 | 27 794 817 | |
| 2020-11-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 36 216 | 60 916 | 146,62 | 79,54 | 2 880 621 | 4 845 259 | |
| 2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 256 | 0 | −100,00 | ||||
| 2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 880 | 0 | −100,00 | ||||
| 2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 256 | 52 732 | 2,44 | 79,54 | 99 902 | 4 194 303 | |
| 2020-08-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 51 486 | 3,79 | 53,18 | 99 988 | 2 738 283 | |
| 2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −37 098 | 0 | −100,00 | ||||
| 2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −37 836 | 0 | −100,00 | ||||
| 2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −8 790 | 0 | −100,00 | ||||
| 2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 049 | 49 596 | −5,79 | 381,48 | −1 163 118 | 18 919 654 | |
| 2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −14 469 | 52 645 | −21,56 | 380,12 | −5 499 962 | 20 011 438 | |
| 2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −37 209 | 67 114 | −35,67 | 379,20 | −14 109 701 | 25 449 716 | |
| 2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −28 997 | 104 323 | −21,75 | 377,84 | −10 956 290 | 39 417 632 | |
| 2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 37 098 | 133 320 | 38,55 | 62,00 | 2 300 076 | 8 265 840 | |
| 2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 37 836 | 96 222 | 64,80 | 53,18 | 2 012 308 | 5 117 567 | |
| 2020-08-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 8 790 | 58 386 | 17,72 | 43,68 | 383 947 | 2 550 300 | |
| 2020-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −193 | 7 481 | −2,51 | ||||
| 2020-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −97 | 49 596 | −0,20 | 395,71 | −38 384 | 19 625 633 | |
| 2020-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 193 | 49 693 | 0,39 | ||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −435 | 7 674 | −5,36 | ||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −505 | 8 109 | −5,86 | ||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −459 | 8 614 | −5,06 | ||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −810 | 9 073 | −8,20 | ||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −628 | 9 883 | −5,97 | ||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 731 | 10 511 | 19,72 | ||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 17 813 | 17 813 | |||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −979 | 49 457 | −1,94 | 288,78 | −282 716 | 14 282 192 | |
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 435 | 50 436 | 0,87 | ||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 50 001 | 1,02 | ||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 49 496 | 0,94 | ||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 810 | 49 037 | 1,68 | ||||
| 2020-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 628 | 48 227 | 1,32 | ||||
| 2019-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 961 | 8 780 | 12,29 | ||||
| 2019-08-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 10 058 | 0 | −100,00 | ||||
| 2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −7 504 | 0 | −100,00 | ||||
| 2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −629 | 47 528 | −1,31 | 248,79 | −156 492 | 11 824 695 |
| 2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −5 771 | 48 157 | −10,70 | 248,28 | −1 432 819 | 11 956 377 |
| 2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −225 | 53 928 | −0,42 | 247,28 | −55 638 | 13 335 375 |
| 2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −375 | 54 153 | −0,69 | 245,77 | −92 165 | 13 309 324 |
| 2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −300 | 54 528 | −0,55 | 244,57 | −73 372 | 13 336 093 |
| 2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −204 | 54 828 | −0,37 | 242,72 | −49 514 | 13 307 611 |
| 2019-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 7 504 | 55 032 | 15,79 | 44,04 | 330 514 | 2 423 884 | |
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −505 | 7 819 | −6,07 | ||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −459 | 8 324 | −5,23 | ||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −811 | 8 783 | −8,45 | ||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −629 | 9 594 | −6,15 | ||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −726 | 10 223 | −6,63 | ||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | 2 175 | 10 949 | 24,79 | ||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | 483 | 483 | |||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | 20 753 | 20 753 | |||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 612 | 47 496 | −3,28 | 206,94 | −333 587 | 9 828 822 | |
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 505 | 49 108 | 1,04 | ||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 48 603 | 0,95 | ||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 811 | 48 144 | 1,71 | ||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 47 333 | 1,35 | ||||
| 2019-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 46 704 | 1,58 | ||||
| 2019-02-13 |
|
4 | ATHN |
ATHENAHEALTH INC
Common Stock |
D - Sale to Issuer | −2 721 | 0 | −100,00 | 135,00 | −367 335 | ||
| 2019-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −2 820 | 8 774 | −24,32 | ||||
| 2019-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 006 | 45 978 | −2,14 | 186,02 | −187 136 | 8 552 828 | |
| 2019-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 48 984 | 6,11 | ||||
| 2018-06-08 |
|
4 | ATHN |
ATHENAHEALTH INC
Common Stock |
A - Award | 1 931 | 2 721 | 244,43 | ||||
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −459 | 11 594 | −3,81 | ||||
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −811 | 12 053 | −6,30 | ||||
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −629 | 12 864 | −4,66 | ||||
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −726 | 13 493 | −5,11 | ||||
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 2 524 | 14 219 | 21,58 | ||||
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 560 | 560 | |||||
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 25 140 | 25 140 | |||||
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −903 | 44 040 | −2,01 | 178,26 | −160 969 | 7 850 570 | |
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 459 | 44 943 | 1,03 | ||||
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 811 | 44 484 | 1,86 | ||||
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 43 673 | 1,46 | ||||
| 2018-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 43 044 | 1,72 | ||||
| 2018-02-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 880 | 1 880 | −50,00 | ||||
| 2018-02-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 42 318 | 4,65 | 53,18 | 99 988 | 2 250 683 | |
| 2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −6 602 | 0 | −100,00 | ||||
| 2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −1 200 | 40 438 | −2,88 | 182,33 | −218 792 | 7 372 923 |
| 2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −3 706 | 41 638 | −8,17 | 181,44 | −672 406 | 7 554 678 |
| 2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −1 696 | 45 344 | −3,61 | 180,53 | −306 171 | 8 185 735 |
| 2018-02-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 6 602 | 47 040 | 16,33 | 38,80 | 256 125 | 1 824 917 | |
| 2018-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −2 820 | 11 695 | −19,43 | ||||
| 2018-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 095 | 40 438 | −2,64 | 156,38 | −171 236 | 6 323 694 | |
| 2018-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 41 533 | 7,28 | ||||
| 2017-09-06 |
|
4 | ATHN |
ATHENAHEALTH INC
Common Stock |
A - Award | 790 | 790 | |||||
| 2017-02-21 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 880 | 3 760 | −33,33 | ||||
| 2017-02-21 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 38 548 | 5,13 | 53,18 | 99 988 | 2 050 175 | |
| 2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −811 | 14 515 | −5,29 | ||||
| 2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −629 | 15 326 | −3,94 | ||||
| 2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −726 | 15 955 | −4,35 | ||||
| 2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 2 295 | 16 681 | 15,95 | ||||
| 2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 706 | 706 | |||||
| 2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 23 326 | 23 326 | |||||
| 2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −809 | 36 668 | −2,16 | 141,60 | −114 554 | 5 192 189 | |
| 2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 811 | 37 477 | 2,21 | ||||
| 2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 36 666 | 1,75 | ||||
| 2017-02-16 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 36 037 | 2,06 | ||||
| 2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 924 | 0 | −100,00 | ||||
| 2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −970 | 35 311 | −2,67 | 142,24 | −137 971 | 5 022 573 |
| 2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −8 954 | 36 281 | −19,79 | 141,57 | −1 267 620 | 5 136 308 |
| 2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 9 924 | 45 235 | 28,10 | 26,66 | 264 524 | 1 205 739 | |
| 2017-01-04 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −2 820 | 14 386 | −16,39 | ||||
| 2017-01-04 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 105 | 35 311 | −3,03 | 117,27 | −129 583 | 4 140 921 | |
| 2017-01-04 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 36 416 | 8,39 | ||||
| 2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −629 | 17 206 | −3,53 | ||||
| 2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −726 | 17 835 | −3,91 | ||||
| 2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 4 053 | 18 561 | 27,94 | ||||
| 2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 1 474 | 1 474 | |||||
| 2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 45 535 | 45 535 | |||||
| 2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −505 | 33 331 | −1,49 | 67,85 | −34 264 | 2 261 508 | |
| 2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 33 816 | 1,90 | ||||
| 2016-05-17 |
|
4/A | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 33 187 | 2,24 | ||||
| 2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −629 | 17 206 | −3,53 | ||||
| 2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −726 | 17 835 | −3,91 | ||||
| 2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 4 053 | 18 561 | 27,94 | ||||
| 2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
A - Award | 1 474 | 1 474 | |||||
| 2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 35 535 | 45 535 | 355,35 | ||||
| 2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −505 | 33 331 | −1,49 | 67,85 | −34 264 | 2 261 508 | |
| 2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 629 | 33 816 | 1,90 | ||||
| 2016-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 726 | 33 187 | 2,24 | ||||
| 2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −9 054 | 0 | −100,00 | ||||
| 2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −4 854 | 32 461 | −13,01 | 70,06 | −340 080 | 2 274 279 |
| 2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −4 200 | 37 315 | −10,12 | 69,17 | −290 507 | 2 581 015 |
| 2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 9 054 | 41 515 | 27,89 | 17,18 | 155 593 | 713 435 | |
| 2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −1 880 | 5 640 | −25,00 | ||||
| 2016-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 880 | 32 461 | 6,15 | 53,18 | 99 988 | 1 726 438 | |
| 2016-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −2 820 | 14 508 | −16,27 | ||||
| 2016-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −1 129 | 30 581 | −3,56 | 72,92 | −82 327 | 2 229 967 | |
| 2016-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 820 | 31 710 | 9,76 | ||||
| 2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
| 2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −3 000 | 14 445 | −17,20 | 157,36 | −472 088 | 2 273 104 |
| 2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −2 000 | 17 445 | −10,29 | 156,44 | −312 873 | 2 729 036 |
| 2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 5 000 | 19 445 | 34,61 | 29,27 | 146 350 | 569 155 | |
| 2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −363 | 8 664 | −4,02 | ||||
| 2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 572 | 9 027 | 21,09 | ||||
| 2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right to buy) |
A - Award | 628 | 628 | |||||
| 2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 18 108 | 18 108 | |||||
| 2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −117 | 14 445 | −0,80 | 159,08 | −18 612 | 2 297 911 | |
| 2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 363 | 14 562 | 2,56 | ||||
| 2015-02-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right to buy) |
M - Exercise | −940 | 3 760 | −20,00 | ||||
| 2015-02-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 940 | 14 199 | 7,09 | 106,37 | 99 988 | 1 510 348 | |
| 2015-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
M - Exercise | −1 411 | 7 455 | −15,91 | ||||
| 2015-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
F - Taxes | −493 | 13 259 | −3,58 | 148,27 | −73 097 | 1 965 912 | |
| 2015-01-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 411 | 13 752 | 11,43 | ||||
| 2014-10-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 934 | 0 | −100,00 | ||||
| 2014-10-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −2 934 | 12 341 | −19,21 | 142,17 | −417 127 | 1 754 520 |
| 2014-10-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 934 | 15 275 | 23,77 | 56,95 | 167 091 | 869 911 | |
| 2014-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 800 | 0 | −100,00 | ||||
| 2014-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | X | −4 800 | 12 341 | −28,00 | 126,05 | −605 040 | 1 555 583 |
| 2014-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 4 800 | 17 141 | 38,89 | 30,50 | 146 376 | 522 715 | |
| 2014-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 1 815 | 8 866 | 25,74 | ||||
| 2014-02-19 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 18 549 | 18 549 | |||||
| 2014-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Restricted Stock Unit |
A - Award | 7 051 | 7 051 | |||||
| 2014-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right to buy) |
A - Award | 4 700 | 4 700 | |||||
| 2014-01-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 18 918 | 18 918 | |||||
| 2013-06-07 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
P - Purchase | 3 600 | 10 991 | 48,71 | 28,61 | 103 010 | 314 495 | |
| 2013-05-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Options (right to buy) |
A - Award | 4 395 | 4 395 | |||||
| 2013-05-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 429 | 7 513 | 6,06 | ||||
| 2013-03-19 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
A - Award | 13 793 | 13 793 | |||||
| 2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Performance Units |
A - Award | 17 021 | 17 021 | |||||
| 2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
D - Sale to Issuer | −6 340 | 12 700 | −33,30 | ||||
| 2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
D - Sale to Issuer | −2 343 | 2 351 | −49,91 | ||||
| 2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
F - Taxes | −2 809 | 7 391 | −27,54 | 35,31 | −99 186 | 260 976 | |
| 2013-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
A - Award | 8 683 | 10 200 | 572,38 | ||||
| 2012-11-26 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
A - Award | 123 | 1 517 | 8,82 | ||||
| 2012-11-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 666 | 0 | −100,00 | ||||
| 2012-11-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −6 666 | 12 341 | −35,07 | 90,48 | −603 152 | 1 116 636 | |
| 2012-11-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 6 666 | 19 007 | 54,02 | 17,12 | 114 089 | 325 305 | |
| 2012-10-22 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 5 942 | 55 440 | 12,00 | ||||
| 2012-10-22 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 9 547 | 89 072 | 12,01 | ||||
| 2012-10-22 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 6 942 | 64 774 | 12,00 | ||||
| 2012-05-11 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 3 752 | 3 752 | |||||
| 2012-05-11 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 369 | 7 084 | 5,50 | ||||
| 2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
D - Sale to Issuer | 2 132 | 4 272 | 99,63 | ||||
| 2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
F - Taxes | −738 | 1 394 | −34,62 | 28,74 | −21 210 | 40 064 | |
| 2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock, par value $.01 per share |
A - Award | 2 132 | 2 132 | |||||
| 2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
A - Award | 17 328 | 17 328 | |||||
| 2012-03-13 |
|
4 | IRM |
IRON MOUNTAIN INC
Performance Units |
A - Award | 14 177 | 14 177 | |||||
| 2012-03-13 |
|
4/A | IRM |
IRON MOUNTAIN INC
Restricted Stock Units |
A - Award | 6 404 | 6 404 | |||||
| 2011-03-15 |
|
4 | IRM |
IRON MOUNTAIN INC
Employee Stock Option (Right to Buy) |
A - Award | 49 498 | 49 498 | |||||
| 2011-03-15 |
|
4 | IRM |
IRON MOUNTAIN INC
Common Stock |
A - Award | 6 404 | 6 404 |
